On May 20, Medline Inc fell 5.31% in pre-market trading, trading at $35.7/share, with trading volume of $822,000.

On the news front, selling stockholders affiliated with Blackstone, Hellman & Friedman, and an Abu Dhabi Investment Authority subsidiary have commenced a public offering of 60 million shares of Medline Class A common stock. The offering is purely a secondary market sale — Medline itself is not selling any shares and will not receive any proceeds from the transaction. The large block size of 60 million shares appears to have pressured the stock in pre-market trading amid concerns over near-term supply overhang.

Notably, the stock had rebounded 6.61% on May 18 following a 6.97% single-day drop on May 16, with Tigress Financial recently raising its target price from $60 to $62 while maintaining a Buy rating. The analyst consensus average target stands at $51.56, suggesting significant upside from current levels despite the selling pressure.

Medline Inc. is the largest supplier of medical-surgical products and supply chain solutions, serving hospitals, surgery centers, physician offices, and post-acute care facilities with critical consumables.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)